| |
|
|
|
Intec Pharma Ltd.  
|
|
0.2975 0.018 (0.06%) |
05-26 09:33 |
|
Open: |
0.313 |
Pre close: |
0.2798 |
Target:
|
0.37 
|
|
High: |
0.3389 |
Low: |
0.29 |
Resistance:
|
0.31
0.38
|
|
Volume: |
1,204,162 |
Market Cap: |
21M |
Support:
|
0.20
0.17
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
0.26
 |
MACD |
MACD(12,26):
|
0.01 |
|
MA(20): |
0.24 |
Signal(12,26,9): |
0.00 |
|
MA(100): |
0.30 |
Stochastic Oscillator |
%K(14,3):
|
37.59 |
|
MA(250): |
1.05 |
%D(3): |
30.93 |
|
Average Volume(K) |
3-Month: |
574064
|
52-Week |
High:
|
5.54 |
|
10-Days: |
1314618 |
Low: |
0.13 |
|
RSI |
RSI(14):
|
60.50 |
Change(%): |
-94.9 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.097 |
Return on Equity (ttm) |
-140.0 |
Shares Out. (M) |
69.27 |
|
EPS Est. Current Year |
-1.670 |
Return on Assets (ttm) |
-42.8 |
Shares Float (M) |
43.60 |
|
EPS Est. Next Year |
-1.250 |
PEG Ratio |
0.00 |
% Held by Insiders |
10.19 |
|
EPS Est. Next Quarter |
-0.700 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
17.02 |
|
Forward EPS |
-1.410 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
32 |
|
Book Value (p.s.) |
0.270 |
EBITDA (p.s.) |
-0.368 |
P/E |
-0.26 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.04 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-26.93 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-19.22 |
P/CF |
-0.72 |
|
|
|
|
|
|
